Blog
RSS FeedPosted by Michael Wonder on 05 Feb 2024
Be thankful for high drug prices
4 February 2024 - If Americans weren’t overcharged, we wouldn’t have innovative treatments. ...
Posted by Michael Wonder on 29 Jan 2024
Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices
26 January 2024 - Bristol Myers Squibb CEO Chris Boerner and another unnamed pharmaceutical CEO accepted initial invitations to testify. ...
Posted by Michael Wonder on 22 Jan 2024
Generic drugs in the US are too cheap to be sustainable, experts say
19 January 2024 - Non-brand-name drugs are one inexpensive part of the healthcare system but they’re driving some manufacturers out of ...
Posted by Michael Wonder on 18 Jan 2024
Drug makers raise prices of Ozempic, Mounjaro and hundreds of other drugs
18 January 2024 - Companies hiked prices of 775 brand name drugs at start of new year. ...
Posted by Michael Wonder on 03 Jan 2024
Drug makers set to raise US prices on at least 500 drugs in January
29 December 2023 - Drug makers including Pfizer, Sanofi and Takeda plan to raise prices in the United States on ...
Posted by Michael Wonder on 11 Dec 2023
ICER identifies most significant 2022 US drug price hikes unsupported by new clinical evidence
11 December 2023 - Of 10 high expenditure drugs that had substantial 2022 net price increases, eight were not supported by ...
Posted by Michael Wonder on 06 Dec 2023
Reimbursement to pharmacies for generic drugs by Medicare Part D sponsors
5 December 2023 - Pharmacy benefit managers (PBMs) manage prescription drug benefits on behalf of health insurers; PBMs negotiate reimbursements for ...
Posted by Michael Wonder on 30 Nov 2023
Prevalence and nature of manufacturer-sponsored patient support programs for prescription drugs in Canada: a cross-sectional study
27 November 2023 - Of the 2556 prescription drugs marketed by 89 companies in the study period, 256 (10.0%) had a ...
Posted by Michael Wonder on 20 Nov 2023
Landmark medicines deal to boost nation’s health, save NHS £14 billion, and support research investment
20 November 2023 - Pro-innovation and pro-competition agreement will introduce a new mechanism to support lower industry payment rates for more ...
Posted by Michael Wonder on 07 Nov 2023
Germany, Belgium and France among those hit hardest as Commission’s Pharma-legislation proposals risk Europe losing a third of its share of global R&D by 2040
6 November 2023 - The European Federation of Pharmaceutical Industries and Associations (EFPIA) is publishing new research which assesses the ...
Posted by Michael Wonder on 12 Sep 2023
The Inflation Reduction Act will lead to fewer new medicines
11 September 2023 - The impact of the Inflation Reduction Act on the biopharmaceutical industry is going to be substantial in ...
Posted by Michael Wonder on 25 Aug 2023
Mid year drug price hikes are back despite Inflation Reduction Act
24 August 2023 - It’s almost a tradition. At the start and halfway points of each year, many pharmaceutical companies ...
Posted by Michael Wonder on 14 Aug 2023
How advocates pushed big pharma to cut tuberculosis drug prices
14 August 2023 - The world’s best tuberculosis drug was too expensive for sufferers—until advocates and a YouTube star changed almost ...
Posted by Michael Wonder on 08 Aug 2023
Don’t believe drug companies: 340B is a program worth saving
8 August 2023 - Here we go again: An op-ed column printed in this publication is yet another example of ...
Posted by Michael Wonder on 25 Jul 2023
Peter Mac increases manufacturing centre for gene therapy bringing new hope to cancer patients
25 July 2023 - Australia’s first biomedical manufacturing facility has opened in Melbourne and will boost lifesaving therapy for cancer patients ...